MEDLIVE (02192) repurchased 75,000 shares on November 6 for HK$491,800.
MEDLIVE (02192) announced that on November 6, 2026, it repurchased 75,000 shares for HK$491,800.
MEDLIVE (02192) announced that on November 6, 2026, it repurchased 75,000 shares for HK$491,800.
Related Articles
Pharmaron Beijing (03759) contributes US$10 million to participate in an overseas equity investment fund.
JF SMARTINVEST (09636) repurchased 95,900 shares for HK$2.3275 million on November 6.
WANG ON PPT (01243) Issues Positive Profit Alert, Expects Interim Profit Attributable to Shareholders of Not Less Than HK$150 Million, Turning from Loss to Profit Year-on-Year
Pharmaron Beijing (03759) contributes US$10 million to participate in an overseas equity investment fund.
JF SMARTINVEST (09636) repurchased 95,900 shares for HK$2.3275 million on November 6.
WANG ON PPT (01243) Issues Positive Profit Alert, Expects Interim Profit Attributable to Shareholders of Not Less Than HK$150 Million, Turning from Loss to Profit Year-on-Year
